How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Energy-based Skin Tightening Market
- By Technology Type: Radiofrequency (RF) Devices, Ultrasound Devices, Laser Devices, Infrared Devices, Microneedling with RF
- By Application Area: Face, Neck, Abdomen, Thighs, Arms
- By End-User: Dermatology Clinics, Medical Spas, Plastic Surgery Clinics, Hospitals, Beauty Salons
- By Procedure Type: Non-invasive Skin Tightening, Minimally Invasive Skin Tightening
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Radiofrequency (RF) Devices leads By Technology Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.165 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.173 →
Full report · locked preview
Everything inside the Energy-based Skin Tightening Market report
A complete, evidence-based study - 11 chapters and 116 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Cutera Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Cynosure (a division of Hologic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Inc.)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Syneron Medical Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Alma Lasers (a subsidiary of Sisram Medical Ltd.)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Lumenis Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Venus Concept Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Sciton Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Fotona d.o.o.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →InMode Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Jeisys Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Hugel Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Mediostar (part of Asclepion Laser Technologies)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →DEKA M.E.L.A. S.r.l.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Zimmer MedizinSysteme GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Radiofrequency (RF) Devices29.6
- Ultrasound Devices14.9
- Laser Devices15.7
- Infrared Devices20.1
- Microneedling with RF19.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Cutera Inc.23.0
- Cynosure (a division of Hologic20.7
- Inc.)12.4
- Syneron Medical Ltd.4.3
- Alma Lasers (a subsidiary of Sisram Medical Ltd.)4.8
- Lumenis Ltd.6.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.6
- Europe23.0
- Asia Pacific23.3
- Latin America12.1
- Middle East and Africa10.1
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Cutera Inc. | 96 | 81 | 87 | 82 | 88 | 97 | 89 |
| Cynosure (a division of Hologic | 70 | 73 | 74 | 87 | 93 | 89 | 81 |
| Inc.) | 84 | 80 | 66 | 74 | 80 | 87 | 79 |
| Syneron Medical Ltd. | 72 | 59 | 74 | 76 | 70 | 76 | 71 |
| Alma Lasers (a subsidiary of Sisram Medical Ltd.) | 75 | 71 | 74 | 52 | 52 | 52 | 63 |
| Lumenis Ltd. | 56 | 48 | 59 | 56 | 48 | 59 | 54 |
| Venus Concept Inc. | 59 | 61 | 46 | 54 | 52 | 40 | 52 |
| Sciton Inc. | 47 | 41 | 58 | 46 | 41 | 57 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Cutera Inc.
- Cynosure (a division of Hologic
- Inc.)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Cutera Inc. | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Cynosure (a division of Hologic | ✓ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Inc.) | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Syneron Medical Ltd. | ◐ | ◐ | ✓ | ✓ | ✓ | ◐ |
| Alma Lasers (a subsidiary of Sisram Medical Ltd.) | ◐ | ◐ | ◐ | − | − | − |
| Lumenis Ltd. | − | − | − | ◐ | ◐ | − |
| Venus Concept Inc. | ◐ | ◐ | − | ◐ | ◐ | − |
| Sciton Inc. | − | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Challenger1
Strong scale, closing on the leaders.
Contender1
Focused players with pockets of strength.
Niche3
Specialists in a single segment or region.
Go-to-market strategy
Land Technology Type in North America, then scale across Energy-based Skin Tightening Market — a $379M beachhead inside a $5.49B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Radiofrequency (RF) Devices
Best fit — highest urgency & budget in Technology Type.
Ultrasound Devices
Strong fit — clear ROI and a fast path to value.
Laser Devices
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Technology Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application Area & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Technology Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Energy-based Skin Tightening Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Energy-based Skin Tightening Market is a durable-growth opportunity — $8.52B by 2033, compounding at 8.4%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.4% CAGR
Demand compounds through 2033, outpacing GDP across Technology Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Technology Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application Area optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Energy-based Skin Tightening Market — a $587M market by 2033. Plan: grow share from 5.6% to 12.1%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.6% | 12.1% | On track |
| Revenue | $33M | $71M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Ahead |
| Gross margin | 36.7% | 42.2% | Ahead |
| Customer retention | 90.7% | 96.4% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Technology Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Application Area capability
A defensible second engine — invest in Application Area to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Technology Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application Area
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $8M capacity & capability investment
- Greenlight bolt-on M&A in Application Area
- Authorise North America expansion plan
- Fund R&D program for Technology Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeBehind
- Execution & talentBehind
Sales deck · value proposition
Win the Energy-based Skin Tightening Market conversation — a $4.36B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Technology Type
Goal Grow share in Technology Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Energy-based Skin Tightening Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Energy-based Skin Tightening Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Vitamin C and Derivatives Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportEnergy Based Medical Aesthetic System Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportPTFE Venting Membrane Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportEnergy-based Aesthetic Treatments Market
Market size, share, segmentation and regional forecast.
$944M market · 2025 base year
View reportOrally Disintegrating Tablet Excipient Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportEndurance Enhancers for Fitness Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View report1-Methylpiperazine Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View report1-Naphthaleneethanol Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportEnd-to-End Exosome Service Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportEnd-tidal CO2 Monitoring Device Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportEnd-Tidal CO2 Module Market
Market size, share, segmentation and regional forecast.
$496M market · 2025 base year
View reportEnd Stage Renal Disease Treatment Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy